Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.

The tissue analysis technology developer has now raised more than $37m, having received $23.6m in a first tranche of its series C round that was led by PHC Holdings.

The personalised therapy management platform closed a round led by Cardinal Health with backing from Novartis and Kite Pharma, taking its overall funding to more than $82m.

EPFL-founded tissue analysis technology developer Lunaphore has now raised $37.3m in all after a series C round led by medical products firm PHC Holdings.

Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.

Oak Ridge spinout Verana Health has completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.

Genomic medicine developer Beam will raise $180m in a upsized initial public offering three years after being spun out of Harvard University.

Alphabet, Editas and Bio Palette-backed genomic medicine developer Beam will raise $180m in an upsized initial public offering three years after being spun out of Harvard University.